jeudi 25 juin 2015

Spotlight on Alexion's pricing of rare-disease drug Soliris

Josh DeBortoli

A special drug for an extremely rare disease, Soliris costs about half a million dollars per patient, per year, for life. Why? The reasons for the price are locked in "the black box" of drug pricing that governments are seeking to crack open.



Source :CBC | Business News http://ift.tt/1e4W1NP

0 commentaires:

Enregistrer un commentaire